Cingulate Inc

CINGNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

13.9M

on 2026-06-30, from 418K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-12 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$200.0M

S-3 of 2026-01-12. 1 prospectus supplement filed under it since. S-3 ↗

$100.0M

Agreement of 2026-03-24. No at-the-market sales statement read from a 10-Q or 10-K. 424B3 ↗

Warrants

2.62M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

5.5 quarters

$28.4M on 2026-06-30 ÷ $5.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-01-27	Private placement	1,868,482	$5.14	not stated	8-K ↗